Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.66)
# 807
Out of 4,667 analysts
133
Total ratings
55.34%
Success rate
4.55%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $30.78 | +20.21% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $333.00 | +20.12% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $144.66 | +16.13% | 8 | Oct 25, 2024 | |
| HUM Humana | Maintains: Outperform | $400 → $280 | $293.97 | -4.75% | 12 | Oct 3, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $120.99 | +19.84% | 10 | Sep 23, 2024 | |
| PACS PACS Group | Maintains: Outperform | $32 → $40 | $17.25 | +131.88% | 3 | Aug 13, 2024 | |
| TDOC Teladoc Health | Maintains: Outperform | $21 → $17 | $9.00 | +88.89% | 10 | Aug 1, 2024 | |
| CNC Centene | Maintains: Outperform | $110 → $95 | $59.10 | +60.74% | 16 | Jul 29, 2024 | |
| CYH Community Health Systems | Maintains: Outperform | $4.5 → $5 | $3.83 | +30.55% | 10 | Jul 25, 2024 | |
| CI The Cigna Group | Maintains: Outperform | $370 → $400 | $323.39 | +23.69% | 10 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $7.46 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $552.87 | +17.57% | 12 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $610 | $600.50 | +1.58% | 13 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $90.00 | +61.11% | 10 | Oct 28, 2022 |
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $30.78
Upside: +20.21%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $333.00
Upside: +20.12%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $144.66
Upside: +16.13%
Humana
Oct 3, 2024
Maintains: Outperform
Price Target: $400 → $280
Current: $293.97
Upside: -4.75%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $120.99
Upside: +19.84%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $17.25
Upside: +131.88%
Teladoc Health
Aug 1, 2024
Maintains: Outperform
Price Target: $21 → $17
Current: $9.00
Upside: +88.89%
Centene
Jul 29, 2024
Maintains: Outperform
Price Target: $110 → $95
Current: $59.10
Upside: +60.74%
Community Health Systems
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.83
Upside: +30.55%
The Cigna Group
May 3, 2024
Maintains: Outperform
Price Target: $370 → $400
Current: $323.39
Upside: +23.69%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $7.46
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $552.87
Upside: +17.57%
Jan 17, 2024
Reiterates: Outperform
Price Target: $610
Current: $600.50
Upside: +1.58%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $90.00
Upside: +61.11%